328 related articles for article (PubMed ID: 19622617)
1. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.
Cussons AJ; Watts GF; Mori TA; Stuckey BG
J Clin Endocrinol Metab; 2009 Oct; 94(10):3842-8. PubMed ID: 19622617
[TBL] [Abstract][Full Text] [Related]
2. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
[TBL] [Abstract][Full Text] [Related]
3. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
[TBL] [Abstract][Full Text] [Related]
6. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome.
Nasri K; Hantoushzadeh S; Aghadavod E; Taghizadeh M; Asemi Z
Horm Metab Res; 2017 Jun; 49(6):446-451. PubMed ID: 28235206
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
[TBL] [Abstract][Full Text] [Related]
11. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Scorletti E; Byrne CD
Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome.
Rafraf M; Mohammadi E; Asghari-Jafarabadi M; Farzadi L
J Am Coll Nutr; 2012 Oct; 31(5):361-8. PubMed ID: 23529993
[TBL] [Abstract][Full Text] [Related]
17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
18. Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.
Ma RC; Liu KH; Lam PM; Cheung LP; Tam WH; Ko GT; Chan MH; Ho CS; Lam CW; Chu WC; Tong PC; So WY; Chan JC; Chow CC
J Clin Endocrinol Metab; 2011 Mar; 96(3):799-807. PubMed ID: 21190980
[TBL] [Abstract][Full Text] [Related]
19. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
Torkildsen O; Wergeland S; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Midgard R; Lilleås F; Pedersen T; Bjørnarå B; Dalene F; Kleveland G; Schepel J; Olsen IC; Myhr KM
Arch Neurol; 2012 Aug; 69(8):1044-51. PubMed ID: 22507886
[TBL] [Abstract][Full Text] [Related]
20. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.
Jamilian M; Shojaei A; Samimi M; Afshar Ebrahimi F; Aghadavod E; Karamali M; Taghizadeh M; Jamilian H; Alaeinasab S; Jafarnejad S; Asemi Z
J Affect Disord; 2018 Mar; 229():41-47. PubMed ID: 29306057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
